MARK2 and pancreatic ductal adenocarcinoma: GSK‐3β is a serine/threonine kinase that plays a role in the development of pancreatic ductal adenocarcinoma (PDAC) by cell proliferation, survival, invasion, metastasis, and resistance to chemotherapy [16, 17].